Report Detail

Request for Sample of this report

Pharma & Healthcare Global Eye Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4673917
    • |
  • 18 February, 2026
    • |
  • Global
    • |
  • 107 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Eye Injection market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Eye Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Eye Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Eye Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Eye Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Eye Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Eye Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Eye Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Novartis, Bayer, Genentech, Apellis Pharmaceuticals, Inc., Coherus BioSciences Inc., Iveric Bio, Regeneron, Roche, Fagron, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Eye Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Ranibizumab
Bevacizumab
Aflibercept
Brolucizumab
Faricimab
Others
Market segment by Application
Age-related Macular Degeneration (AMD)
Diabetic Retinopathy
Retinal Vein Occlusion (RVO)
Retinopathy of Prematurity (ROP)
Uveitis
Neovascular Glaucoma
Others
Major players covered
Sanofi
Novartis
Bayer
Genentech
Apellis Pharmaceuticals, Inc.
Coherus BioSciences Inc.
Iveric Bio
Regeneron
Roche
Fagron
Qilu Pharmaceutical Co.,Ltd.
Chengdu Kanghong Pharmaceutical Group
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Eye Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Eye Injection, with price, sales quantity, revenue, and global market share of Eye Injection from 2021 to 2026.
Chapter 3, the Eye Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Eye Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Eye Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Eye Injection.
Chapter 14 and 15, to describe Eye Injection sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Eye Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Ranibizumab
    • 1.3.3 Bevacizumab
    • 1.3.4 Aflibercept
    • 1.3.5 Brolucizumab
    • 1.3.6 Faricimab
    • 1.3.7 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Eye Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Age-related Macular Degeneration (AMD)
    • 1.4.3 Diabetic Retinopathy
    • 1.4.4 Retinal Vein Occlusion (RVO)
    • 1.4.5 Retinopathy of Prematurity (ROP)
    • 1.4.6 Uveitis
    • 1.4.7 Neovascular Glaucoma
    • 1.4.8 Others
  • 1.5 Global Eye Injection Market Size & Forecast
    • 1.5.1 Global Eye Injection Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Eye Injection Sales Quantity (2021-2032)
    • 1.5.3 Global Eye Injection Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Sanofi
    • 2.1.1 Sanofi Details
    • 2.1.2 Sanofi Major Business
    • 2.1.3 Sanofi Eye Injection Product and Services
    • 2.1.4 Sanofi Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Sanofi Recent Developments/Updates
  • 2.2 Novartis
    • 2.2.1 Novartis Details
    • 2.2.2 Novartis Major Business
    • 2.2.3 Novartis Eye Injection Product and Services
    • 2.2.4 Novartis Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Novartis Recent Developments/Updates
  • 2.3 Bayer
    • 2.3.1 Bayer Details
    • 2.3.2 Bayer Major Business
    • 2.3.3 Bayer Eye Injection Product and Services
    • 2.3.4 Bayer Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Bayer Recent Developments/Updates
  • 2.4 Genentech
    • 2.4.1 Genentech Details
    • 2.4.2 Genentech Major Business
    • 2.4.3 Genentech Eye Injection Product and Services
    • 2.4.4 Genentech Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Genentech Recent Developments/Updates
  • 2.5 Apellis Pharmaceuticals, Inc.
    • 2.5.1 Apellis Pharmaceuticals, Inc. Details
    • 2.5.2 Apellis Pharmaceuticals, Inc. Major Business
    • 2.5.3 Apellis Pharmaceuticals, Inc. Eye Injection Product and Services
    • 2.5.4 Apellis Pharmaceuticals, Inc. Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Apellis Pharmaceuticals, Inc. Recent Developments/Updates
  • 2.6 Coherus BioSciences Inc.
    • 2.6.1 Coherus BioSciences Inc. Details
    • 2.6.2 Coherus BioSciences Inc. Major Business
    • 2.6.3 Coherus BioSciences Inc. Eye Injection Product and Services
    • 2.6.4 Coherus BioSciences Inc. Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Coherus BioSciences Inc. Recent Developments/Updates
  • 2.7 Iveric Bio
    • 2.7.1 Iveric Bio Details
    • 2.7.2 Iveric Bio Major Business
    • 2.7.3 Iveric Bio Eye Injection Product and Services
    • 2.7.4 Iveric Bio Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Iveric Bio Recent Developments/Updates
  • 2.8 Regeneron
    • 2.8.1 Regeneron Details
    • 2.8.2 Regeneron Major Business
    • 2.8.3 Regeneron Eye Injection Product and Services
    • 2.8.4 Regeneron Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Regeneron Recent Developments/Updates
  • 2.9 Roche
    • 2.9.1 Roche Details
    • 2.9.2 Roche Major Business
    • 2.9.3 Roche Eye Injection Product and Services
    • 2.9.4 Roche Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Roche Recent Developments/Updates
  • 2.10 Fagron
    • 2.10.1 Fagron Details
    • 2.10.2 Fagron Major Business
    • 2.10.3 Fagron Eye Injection Product and Services
    • 2.10.4 Fagron Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Fagron Recent Developments/Updates
  • 2.11 Qilu Pharmaceutical Co.,Ltd.
    • 2.11.1 Qilu Pharmaceutical Co.,Ltd. Details
    • 2.11.2 Qilu Pharmaceutical Co.,Ltd. Major Business
    • 2.11.3 Qilu Pharmaceutical Co.,Ltd. Eye Injection Product and Services
    • 2.11.4 Qilu Pharmaceutical Co.,Ltd. Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
  • 2.12 Chengdu Kanghong Pharmaceutical Group
    • 2.12.1 Chengdu Kanghong Pharmaceutical Group Details
    • 2.12.2 Chengdu Kanghong Pharmaceutical Group Major Business
    • 2.12.3 Chengdu Kanghong Pharmaceutical Group Eye Injection Product and Services
    • 2.12.4 Chengdu Kanghong Pharmaceutical Group Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates

3 Competitive Environment: Eye Injection by Manufacturer

  • 3.1 Global Eye Injection Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Eye Injection Revenue by Manufacturer (2021-2026)
  • 3.3 Global Eye Injection Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Eye Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Eye Injection Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Eye Injection Manufacturer Market Share in 2025
  • 3.5 Eye Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Eye Injection Market: Region Footprint
    • 3.5.2 Eye Injection Market: Company Product Type Footprint
    • 3.5.3 Eye Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Eye Injection Market Size by Region
    • 4.1.1 Global Eye Injection Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Eye Injection Consumption Value by Region (2021-2032)
    • 4.1.3 Global Eye Injection Average Price by Region (2021-2032)
  • 4.2 North America Eye Injection Consumption Value (2021-2032)
  • 4.3 Europe Eye Injection Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Eye Injection Consumption Value (2021-2032)
  • 4.5 South America Eye Injection Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Eye Injection Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Eye Injection Sales Quantity by Type (2021-2032)
  • 5.2 Global Eye Injection Consumption Value by Type (2021-2032)
  • 5.3 Global Eye Injection Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Eye Injection Sales Quantity by Application (2021-2032)
  • 6.2 Global Eye Injection Consumption Value by Application (2021-2032)
  • 6.3 Global Eye Injection Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Eye Injection Sales Quantity by Type (2021-2032)
  • 7.2 North America Eye Injection Sales Quantity by Application (2021-2032)
  • 7.3 North America Eye Injection Market Size by Country
    • 7.3.1 North America Eye Injection Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Eye Injection Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Eye Injection Sales Quantity by Type (2021-2032)
  • 8.2 Europe Eye Injection Sales Quantity by Application (2021-2032)
  • 8.3 Europe Eye Injection Market Size by Country
    • 8.3.1 Europe Eye Injection Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Eye Injection Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Eye Injection Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Eye Injection Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Eye Injection Market Size by Region
    • 9.3.1 Asia-Pacific Eye Injection Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Eye Injection Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Eye Injection Sales Quantity by Type (2021-2032)
  • 10.2 South America Eye Injection Sales Quantity by Application (2021-2032)
  • 10.3 South America Eye Injection Market Size by Country
    • 10.3.1 South America Eye Injection Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Eye Injection Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Eye Injection Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Eye Injection Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Eye Injection Market Size by Country
    • 11.3.1 Middle East & Africa Eye Injection Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Eye Injection Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Eye Injection Market Drivers
  • 12.2 Eye Injection Market Restraints
  • 12.3 Eye Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Eye Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Eye Injection
  • 13.3 Eye Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Eye Injection Typical Distributors
  • 14.3 Eye Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Eye Injection. Industry analysis & Market Report on Eye Injection is a syndicated market report, published as Global Eye Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Eye Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo